XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 3,000 $ 82,446,000 $ (65,610,000) $ 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,930      
Common Stock issued to directors 54,000 54,000
Common Stock issued to directors (in Shares) 11,430      
Stock-Based Compensation 45,000 45,000
Net income (Loss) (618,000) (618,000)
Balance at Mar. 31, 2023 $ 3,000 82,545,000 (66,228,000) 16,320,000
Balance (in Shares) at Mar. 31, 2023 3,259,360      
Balance at Dec. 31, 2022 $ 3,000 82,446,000 (65,610,000) 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,930      
Net income (Loss)       (2,312,000)
Balance at Sep. 30, 2023 $ 3,000 82,868,000 (67,922,000) 14,949,000
Balance (in Shares) at Sep. 30, 2023 3,289,820      
Balance at Mar. 31, 2023 $ 3,000 82,545,000 (66,228,000) 16,320,000
Balance (in Shares) at Mar. 31, 2023 3,259,360      
Common Stock issued to directors 54,000 54,000
Common Stock issued to directors (in Shares) 15,230      
Stock-Based Compensation 187,000 187,000
Net income (Loss) (395,000) (395,000)
Balance at Jun. 30, 2023 $ 3,000 82,786,000 (66,623,000) 16,166,000
Balance (in Shares) at Jun. 30, 2023 3,274,590      
Common Stock issued to directors 54,000 54,000
Common Stock issued to directors (in Shares) 15,230      
Stock-Based Compensation 28,000 28,000
Net income (Loss) (1,299,000) (1,299,000)
Balance at Sep. 30, 2023 $ 3,000 82,868,000 (67,922,000) 14,949,000
Balance (in Shares) at Sep. 30, 2023 3,289,820      
Balance at Dec. 31, 2023 $ 3,000 82,928,000 (67,741,000) 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Common Stock issued to directors 38,000 38,000
Common Stock issued to directors (in Shares) 12,323      
Stock-Based Compensation 24,000 24,000
Net income (Loss) (706,000) (706,000)
Balance at Mar. 31, 2024 $ 3,000 82,990,000 (68,447,000) 14,546,000
Balance (in Shares) at Mar. 31, 2024 3,315,368      
Balance at Dec. 31, 2023 $ 3,000 82,928,000 (67,741,000) 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Exercise of Stock Options (in Shares) 15,229      
Net income (Loss)       (812,000)
Balance at Sep. 30, 2024 $ 3,000 83,230,000 (68,553,000) 14,680,000
Balance (in Shares) at Sep. 30, 2024 3,350,791      
Balance at Mar. 31, 2024 $ 3,000 82,990,000 (68,447,000) 14,546,000
Balance (in Shares) at Mar. 31, 2024 3,315,368      
Common Stock issued to directors 38,000 38,000
Common Stock issued to directors (in Shares) 7,942      
Stock-Based Compensation 12,000 12,000
Exercise of Stock Options
Exercise of Stock Options (in Shares) 1,475      
Net income (Loss) 298,000 298,000
Balance at Jun. 30, 2024 $ 3,000 83,040,000 (68,149,000) 14,894,000
Balance (in Shares) at Jun. 30, 2024 3,324,785      
Common Stock issued to directors   40,000   40,000
Common Stock issued to directors (in Shares) 12,252      
Stock-Based Compensation   150,000   150,000
Exercise of Stock Options (in Shares) 13,754      
Net income (Loss)     (404,000) (404,000)
Balance at Sep. 30, 2024 $ 3,000 $ 83,230,000 $ (68,553,000) $ 14,680,000
Balance (in Shares) at Sep. 30, 2024 3,350,791